Advances in artificial intelligence and machine learning coupled with the availability of big data and massive data sharing initiatives allows for novel approaches for drug discovery. One of the areas of biomedicine that is commonly overlooked by the for-profit biopharmaceutical companies and investors is antibiotics. Here we would like to facilitate collaboration among the leading AI/ML scientists to collaborate on antiinfectives in order to initiate programs requiring long-term clinical development efforts as well as the rapid response to global pandemics and threats.

We are awesome
  • Alán Aspuru-Guzik
    University of Toronto
  • Alexey Baimiev
    IBG RAN Ufa
  • Connor W. Coley
    Chemical Engineering, MIT
  • Yan Ivanenkov
    Insilico Medicine
  • Alexander Mazhuga
    D. Mendeleev University
  • Ilya Osterman
  • Dmitriy Skvortsov
    Lomonosov MSU
  • Alex Zhavoronkov
    Insilico Medicine
Our partners
If you are interested in becoming a partner or sponsor, please feel free to write us.
Our contacts
Feel free to write and call us
+1 123 456 78 90
Hong Kong: 307A, Core Building 1, 1 Science Park East Avenue, Hong Kong Science Park, Pak Shek Kok

US: 9601 Medical Center Dr, Suite 127 Rockville, MD 20850

Taipei: 17F No.3 Park Street, Nangang District, Taipei Taiwan, Republic of China

Shanghai: Room 5-129, No.1 South building, JinChuang Mansion No.4560 Jinke RoadZhangjiang Hi-Tech Park, Pudong District